| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000023125 |
| Receipt No. | R000026656 |
| Official scientific title of the study | Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma |
| Date of disclosure of the study information | 2016/07/12 |
| Last modified on | 2016/07/12 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma | |
| Title of the study (Brief title) | Risk factors for latent distant organ metastasis in patients with locally advanced pancreatic ductal adenocarcinoma | |
| Region |
|
|
| Condition | |||
| Condition | data collected | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To identify risk factors for latent distant organ metastasis in patients with radiographically defined locally advanced (RDLA) pancreatic ductal adenocarcinoma (PDAC). |
| Basic objectives2 | Others |
| Basic objectives -Others | morbidity of latent distant organ metastasis in patients with RDLA-PDAC |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Risk factors for latent distant organ metastasis in patients with radiographically defined locally advanced (RDLA) pancreatic ductal adenocarcinoma (PDAC). |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | radiographycally-defined locally advanced PDAC | |||
| Key exclusion criteria | Patients who denied staging laparoscopy | |||
| Target sample size | 110 | |||
| Research contact person | |
| Name of lead principal investigator | Sohei SATOI MD, FACS |
| Organization | Kansai Medical University |
| Division name | Surgery |
| Address | 2-5-1, Shin-machi, Hirakata OSAKA, JAPAN |
| TEL | +81-72-804-0101 |
| satoi@hirakata.kmu.ac.jp | |
| Public contact | |
| Name of contact person | Sohei SATOI MD, FACS |
| Organization | Kansai Medical University |
| Division name | Surgery |
| Address | 2-5-1, Shin-machi, Hirakata OSAKA, JAPAN |
| TEL | +81-72-804-0101 |
| Homepage URL | |
| satoi@hirakata.kmu.ac.jp | |
| Sponsor | |
| Institute | Kansai medical university |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | The presence or not of minute distant organmetastasis using staging laparoscopy in patients with RDLA-PDAC |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026656 |